Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 28 01:27PM ET
68.11
Dollar change
+0.42
Percentage change
0.61
%
CategoryUS Equities - Industry Sector Asset TypeEquities (Stocks) TagsU.S. Return% 1Y18.38% Shs Outstand Perf Week1.41%
SponsorBlackrock (iShares) ETF Type Tagsequity Return% 3Y7.01% Total Holdings39 Perf Month-0.64%
Fund Family Bond Type Tagspharmaceutical Return% 5Y7.52% AUM656.87M Perf Quarter10.00%
IndexDow Jones US Sel Pharmaceuticals Indx Average Maturity Tags- Return% 10Y NAV% Perf Half Y14.56%
Index Weighting Commodity Type Tags- Return% SI NAV/sh Perf Year17.90%
Active/Passive Quant Type Tags- Flows% 1M-1.99% 52W Range55.36 - 69.56 Perf YTD10.22%
Dividend TTM0.91 (1.33%) ESG Type Tags- Flows% 3M-3.52% 52W High-2.08% Beta0.66
Dividend Ex-DateDec 20, 2023 Dividend Type Sector/Theme Flows% YTD-4.81% 52W Low23.03% ATR (14)0.65
Expense0.40% Structure Type Region Flows% 1Y RSI (14)58.68 Volatility0.74% 0.96%
Option/ShortYes / Yes Growth/Value Dev/Emerg Flows% 3Y Rel Volume0.53 Prev Close67.70
Inverse/Leveraged Market Cap Currency Flows% 5Y Avg Volume63.67K Price68.11
SMA200.99% SMA502.31% SMA20010.20% Trades Volume21,460 Change0.61%
Dec-21-23 01:45PM
Sep-20-22 03:13PM
Feb-11-22 11:21AM
Apr-09-20 01:20PM
Feb-07-20 11:05AM
01:00PM Loading…
Jan-16-20 01:00PM
Jan-15-20 01:32PM
Dec-20-19 08:10AM
Nov-06-19 11:00AM
Oct-16-19 10:05AM
Oct-15-19 06:43PM
Sep-11-19 04:43PM
Aug-27-19 04:11PM
Aug-22-19 11:12AM
Aug-07-19 10:59AM
10:50AM Loading…
Jul-17-19 10:50AM
Jul-14-19 11:00AM
Jun-26-19 11:00AM
Jun-25-19 06:01PM
May-14-19 05:40PM
May-09-19 10:05AM
Apr-18-19 05:00PM
Apr-17-19 10:35AM
Apr-09-19 02:14PM
Mar-13-19 06:30AM
Mar-01-19 08:00AM
Feb-21-19 10:08AM
Feb-14-19 01:43PM
Feb-07-19 11:15AM
Jan-29-19 09:08AM
10:59AM Loading…
Jan-23-19 10:59AM
Jan-07-19 09:27AM
Jan-04-19 10:01AM
Dec-27-18 09:35AM
Dec-14-18 03:32PM
09:28AM
Oct-22-18 03:30PM
Oct-09-18 11:39AM
Sep-06-18 04:56PM
Aug-28-18 06:40PM
Jul-03-18 03:19PM
Jun-08-18 04:01PM
May-11-18 03:42PM
Apr-24-18 06:41AM
Jan-26-18 10:32AM
Jan-18-18 02:28PM
Jan-11-18 09:02AM
Jan-10-18 08:16AM
Nov-13-17 07:00AM
Oct-30-17 12:25PM
Sep-26-17 01:55PM
01:55PM
Sep-22-17 01:14PM
09:40AM
Sep-11-17 09:06AM
Sep-08-17 09:07AM
Sep-01-17 09:06AM
Aug-31-17 03:02PM
01:39PM
01:05PM
Aug-30-17 02:27PM
Aug-29-17 07:40AM
Aug-28-17 10:36AM
Aug-23-17 01:30PM
Aug-22-17 10:36AM
Aug-18-17 02:37PM
02:37PM
Aug-14-17 02:52PM
12:01PM
Aug-11-17 05:35PM
Aug-09-17 11:34AM
Aug-08-17 11:37AM
Aug-07-17 01:30PM
11:24AM
09:45AM
Aug-04-17 02:11PM
Aug-03-17 11:34AM
Jul-31-17 04:24PM
02:38PM
Jul-28-17 02:00PM
09:42AM
Jul-27-17 11:25AM
10:35AM
Jul-26-17 02:38PM
Jul-24-17 10:35AM
09:40AM
09:13AM
07:38AM
Jul-20-17 09:40AM
Jul-19-17 11:55AM
Jul-18-17 12:32PM
12:32PM
12:32PM
11:40AM
09:24AM
Jul-17-17 07:38AM
Jul-14-17 02:10PM
11:35AM
07:40AM
Jul-11-17 01:34PM
iShares U.S. Pharmaceuticals ETF seeks to track the investment results of the Dow Jones U.S. Select Pharmaceuticals Index. The fund generally will invest at least 80% of its assets in the component securities of its underlying index and in investments that have economic characteristics that are substantially identical to the component securities of its underlying index. The underlying index measures the performance of the pharmaceuticals sector of the U.S. equity market. The underlying index includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines. The fund is non-diversified.